Biotech News

LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026

LENSAR (LNSR)LENSAREarnings

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2026 financial results will be released before market open on Tuesday, November 10, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Tuesday, November 10, 2026 to discuss the results and recent operational highlights.

Related news

LENSAR

Robotic Cataract Technology LENSAR develops advanced laser systems for cataract surgery. Its technology is intended to automate key surgical steps and help ophthalmic surgeons plan and execute precise, astigmatism-aware procedures. ALLY System The ALLY Robotic Cataract Laser System combines imaging, planning and femtosecond-laser...

Recent company news

Stock data

Close
4.64 USD
Market cap
69.48M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States